Differential diagnosis between pancreatic involvement in IgG4-related disease and pancreatic cancer.

[1]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[2]  Y. Guo,et al.  Clinical Utility of FDG PET/CT in Patients with Autoimmune Pancreatitis: a Case-Control Study , 2018, Scientific Reports.

[3]  Fiona Campbell,et al.  PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. , 2018, Health technology assessment.

[4]  B. Barron,et al.  Oncologic 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: What All Physicians Need to Know. , 2017, The American journal of medicine.

[5]  D. Sahani,et al.  Imaging and Screening of Pancreatic Cancer. , 2017, Radiologic clinics of North America.

[6]  P. Kongkam,et al.  Endoscopic ultrasound elastography for solid pancreatic lesions , 2017, World journal of gastrointestinal endoscopy.

[7]  T. Mimori,et al.  Current approach to the diagnosis of IgG4-related disease – Combination of comprehensive diagnostic and organ-specific criteria , 2017, Modern rheumatology.

[8]  J. A. Gómez-Puerta,et al.  IgG4-related disease: A concise review of the current literature. , 2017, Reumatologia clinica.

[9]  Kurinchi Selvan Gurusamy,et al.  Imaging modalities for characterising focal pancreatic lesions. , 2017, The Cochrane database of systematic reviews.

[10]  J. Iglesias-Garcia,et al.  Differential diagnosis of solid pancreatic masses: contrast-enhanced harmonic (CEH-EUS), quantitative-elastography (QE-EUS), or both? , 2017, United European gastroenterology journal.

[11]  P. Lipsky,et al.  Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease , 2017, Arthritis Research & Therapy.

[12]  F. Izzo,et al.  Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update , 2016, Infectious Agents and Cancer.

[13]  R. Chapman,et al.  IgG4-related hepatobiliary disease: an overview , 2016, Nature Reviews Gastroenterology &Hepatology.

[14]  J. Winter,et al.  Pancreatic Cancer: A Review. , 2016, Gastroenterology clinics of North America.

[15]  Matthew D. Mitchell,et al.  Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma: A Meta-Analysis , 2016, Pancreas.

[16]  R. Pozzi Mucelli,et al.  Ultrasound-guided percutaneous fine-needle aspiration of solid pancreatic neoplasms: 10-year experience with more than 2,000 cases and a review of the literature , 2016, European Radiology.

[17]  Jinming Li,et al.  Diagnostic Value of Serum IgG4 for IgG4-Related Disease , 2016, Medicine.

[18]  P. Klenerman,et al.  Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort , 2016, The American Journal of Gastroenterology.

[19]  N. Kawada,et al.  Elastography for the pancreas: Current status and future perspective. , 2016, World journal of gastroenterology.

[20]  W. Egner,et al.  Falsely low immunoglobulin (Ig)G4 in routine analysis: how not to miss IgG4 disease , 2016, Clinical and experimental immunology.

[21]  J. Stone,et al.  International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease , 2015, Arthritis & rheumatology.

[22]  K. Ohmura,et al.  Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease , 2015, BMC Musculoskeletal Disorders.

[23]  J. Stone,et al.  IgG4-related disease , 2015, The Lancet.

[24]  J. Stone,et al.  The clinical spectrum of IgG4-related disease. , 2014, Autoimmunity reviews.

[25]  H. Ono,et al.  Diagnosis of autoimmune pancreatitis. , 2014, World journal of gastroenterology.

[26]  M. Pérez-Miranda,et al.  Role of endoscopic ultrasound in the diagnosis of pancreatic cancer. , 2014, World journal of gastrointestinal oncology.

[27]  K. Uchida,et al.  Recent Advances in the Concept and Pathogenesis of IgG4-Related Disease in the Hepato-Bilio-Pancreatic System , 2014, Gut and liver.

[28]  H. Carr-Smith,et al.  Calibration Differences and the Prozone Phenomenon in IgG4‐Related Disease: Comment on the Article by Khosroshahi et al , 2014, Arthritis & rheumatology.

[29]  Eun Sun Lee,et al.  Imaging diagnosis of pancreatic cancer: a state-of-the-art review. , 2014, World journal of gastroenterology.

[30]  H. Jang,et al.  IgG4-related disease in the abdomen: a great mimicker. , 2014, Seminars in ultrasound, CT, and MR.

[31]  J. Stone,et al.  Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations , 2014, Annals of the rheumatic diseases.

[32]  Hua Chen,et al.  Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  Vikram Deshpande,et al.  The diagnostic utility of serum IgG4 concentrations in IgG4-related disease , 2014, Annals of the rheumatic diseases.

[34]  K. Jhaveri,et al.  Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis. , 2014, AJR. American journal of roentgenology.

[35]  J. Stone,et al.  Prevalence of atopy, eosinophilia, and IgE elevation in IgG4‐related disease , 2014, Allergy.

[36]  Arezou Khosroshahi,et al.  Brief Report: Spuriously Low Serum IgG4 Concentrations Caused by the Prozone Phenomenon in Patients With IgG4‐Related Disease , 2014, Arthritis & rheumatology.

[37]  W. Xu,et al.  Endoscopic ultrasound elastography for differentiation of benign and malignant pancreatic masses: a systemic review and meta-analysis , 2013, European journal of gastroenterology & hepatology.

[38]  D. Sahani,et al.  Consensus statement on the pathology of IgG4-related disease , 2012, Modern Pathology.

[39]  U. Ballehaninna,et al.  The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. , 2012, Journal of gastrointestinal oncology.

[40]  J. Stone,et al.  IgG4-related disease. , 2012, The New England journal of medicine.

[41]  T. Hibi,et al.  Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 , 2012, Modern rheumatology.

[42]  E. Alper,et al.  Comparison of multidetector CT and endoscopic ultrasonography in malignant pancreatic mass lesions. , 2011, Hepato-gastroenterology.

[43]  M. Baltatzis,et al.  Autoimmune pancreatitis versus pancreatic cancer: a comprehensive review with emphasis on differential diagnosis. , 2011, Hepatobiliary & pancreatic diseases international : HBPD INT.

[44]  Myung-Hwan Kim,et al.  International Consensus Diagnostic Criteria for Autoimmune Pancreatitis: Guidelines of the International Association of Pancreatology , 2011, Pancreas.

[45]  J. Iglesias-Garcia,et al.  EUS elastography for the characterization of solid pancreatic masses. , 2009, Gastrointestinal endoscopy.

[46]  B. Petersen,et al.  A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[47]  A. Ignee,et al.  Indications and limitations of endoscopic ultrasound elastography for evaluation of focal pancreatic lesions , 2008, Endoscopy.

[48]  B. Petersen,et al.  Value of Serum IgG4 in the Diagnosis of Autoimmune Pancreatitis and in Distinguishing It From Pancreatic Cancer , 2007, The American Journal of Gastroenterology.

[49]  J. Janssen,et al.  EUS elastography of the pancreas: feasibility and pattern description of the normal pancreas, chronic pancreatitis, and focal pancreatic lesions. , 2007, Gastrointestinal endoscopy.

[50]  S. Chari.  Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria , 2007, Journal of Gastroenterology.

[51]  Daniel F Hayes,et al.  ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  G. Monges,et al.  Endoscopic Ultrasound Elastography: the First Step towards Virtual Biopsy? Preliminary Results in 49 Patients , 2006, Endoscopy.

[53]  J. Sastre,et al.  Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis , 2005, Gut.

[54]  D. Schilling,et al.  Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study , 2000, The Lancet.

[55]  M. McKinstry,et al.  CA19-9 and pancreatic cancer. , 1989, Annals of internal medicine.

[56]  J. Kleeff,et al.  Pancreatic cancer , 1988, Nature Reviews Disease Primers.

[57]  F. Huang,et al.  Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases. , 2016, Clinical and experimental rheumatology.

[58]  Adriana Lorena Gómez Molinar,et al.  Pancreatitis autoinmune. Rol del endoscopista , 2016 .

[59]  Ivan Pedrosa,et al.  Structured reporting of multiphasic CT for pancreatic cancer: potential effect on staging and surgical planning. , 2015, Radiology.

[60]  Q. Ma,et al.  CA 19-9 and pancreatic cancer. , 2013, Clinical advances in hematology & oncology : H&O.

[61]  M. Hidalgo.  Pancreatic cancer. , 2010, The New England journal of medicine.